Published in Antimicrob Agents Chemother on February 01, 2003
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug. Front Microbiol (2012) 1.11
Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist (2014) 1.08
In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis. Antimicrob Agents Chemother (2010) 0.96
Treatment of echinococcosis: albendazole and mebendazole--what else? Parasite (2014) 0.96
Bioinformatic prediction of epitopes in the Emy162 antigen of Echinococcus multilocularis. Exp Ther Med (2013) 0.92
Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother (2003) 0.91
In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae. Antimicrob Agents Chemother (2006) 0.87
Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis. Antimicrob Agents Chemother (2005) 0.86
In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother (2011) 0.83
Gerbu adjuvant modulates the immune response and thus the course of infection in C56BL/6 mice immunised with Echinococcus multilocularis rec14-3-3 protein. Parasitol Res (2010) 0.79
In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis. Parasitol Res (2013) 0.77
A Rapid and Convenient Method for in Vivo Fluorescent Imaging of Protoscolices of Echinococcus multilocularis. Korean J Parasitol (2016) 0.75
Comparison of Scolicidal Effects of Amphotricin B, Silver Nanoparticles,_and Foeniculum vulgare Mill on Hydatid Cysts Protoscoleces. Iran J Parasitol (2015) 0.75
Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions. PLoS Negl Trop Dis (2017) 0.75
Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bull World Health Organ (1996) 4.87
Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull World Health Organ (1986) 2.57
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis (1992) 2.41
Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet (1983) 1.88
Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Swiss Echinococcosis Study Group. Hepatology (1994) 1.82
Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology (1997) 1.68
Amphotericin B: new life for an old drug. Trends Pharmacol Sci (1996) 1.45
Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother (1999) 1.40
Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother (2000) 1.35
Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am J Trop Med Hyg (1990) 1.30
A monoclonal antibody against Echinococcus multilocularis Em2 antigen. Parasitology (1991) 1.28
Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model. Antimicrob Agents Chemother (1998) 1.19
Immunology and morphology studies on the proliferation of in vitro cultivated Echinococcus multilocularis metacestodes. Parasitol Res (1995) 1.18
Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions. J Membr Biol (1996) 1.16
A sequential mechanism for the formation of aqueous channels by amphotericin B in liposomes. The effect of sterols and phospholipid composition. Biochim Biophys Acta (1992) 1.11
Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy. Am J Trop Med Hyg (1987) 1.02
The effects of albendazole and albendazole sulphoxide combination-therapy on Echinococcus granulosus in vitro. Int J Parasitol (1994) 1.02
Interaction of the polyene antibiotic amphotericin B with model membranes: differences between small and large unilamellar vesicles. Biochimie (1989) 1.01
The polyene antibiotic amphotericin B inhibits the Na+/K+ pump of human erythrocytes. Biochem Biophys Res Commun (1988) 0.99
Hepatic tissue culture model for study of host-parasite interactions in alveolar echinococcosis. Infect Immun (1996) 0.99
Rates of amphotericin B and filipin association with sterols. A study of changes in sterol structure and phospholipid composition of vesicles. J Biol Chem (1985) 0.98
Consequences of continuous mebendazole therapy in alveolar hydatid disease--with a summary of a ten-year clinical trial. Ann Trop Med Parasitol (1986) 0.98
Interaction of amphotericin B and its N-fructosyl derivative with murine thymocytes: a comparative study using fluorescent membrane probes. Biochim Biophys Acta (1989) 0.96
Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis. J Hepatol (1998) 0.95
In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother (1998) 0.91
In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections. Am J Trop Med Hyg (1999) 0.91
Failure of treatment with alpha-difluoromethylornithine against secondary multilocular echinococcosis in mice. Parasitol Res (1993) 0.90
Amphotericin B: an update. Br J Biomed Sci (1996) 0.89
Amphotericin B and Nystatin show different activities on sterol-free vesicles. Biochem Biophys Res Commun (1989) 0.84
Detection of antibodies against glycolipids of Echinococcus multilocularis metacestodes in sera of patients with alveolar hydatid disease. Parasite Immunol (1991) 0.83
Analysis of the monohexosylceramide fraction of Echinococcus multilocularis metacestodes. Mol Biochem Parasitol (1990) 0.82
Inhibition of erythrocyte ghost ATPase by polyene antibiotics. Biochem Int (1990) 0.81
Perturbation of the fluidity of the erythrocyte membrane with ionophoric antibiotics and lipophilic anaesthetics. Biochem Pharmacol (1991) 0.81
Enhanced larval cyst growth of Echinococcus multilocularis in praziquantel-treated jirds (Meriones unguiculatus). Am J Trop Med Hyg (1994) 0.80
Influence of amphotericin B on the transport of phosphate, sulphate and potassium ions across the human erythrocyte membrane. Acta Haematol (1988) 0.79
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop (2009) 7.90
Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet (2011) 3.95
European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis (2003) 3.80
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis (2007) 2.92
Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest (2009) 2.12
Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum (2009) 2.04
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis (2004) 1.99
Cystic echinococcosis in sub-Saharan Africa. Lancet Infect Dis (2012) 1.91
Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun (2007) 1.87
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis (2005) 1.78
An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med (2008) 1.71
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis (2004) 1.68
Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health (2006) 1.56
Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health (2006) 1.50
Omenn syndrome due to ARTEMIS mutations. Blood (2005) 1.47
Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis (2004) 1.46
[Fox tapeworm. Is there a risk also in our cities? (interview by Dr. Th. Meissner)]. MMW Fortschr Med (2003) 1.38
Close relationship between clinical regression and specific serology in the follow-up of patients with alveolar echinococcosis in different clinical stages. Am J Trop Med Hyg (2009) 1.16
Buruli ulcer: a systemic disease. Clin Infect Dis (2003) 1.16
Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles. Int J Parasitol (2007) 1.15
Diversification of the insulin receptor family in the helminth parasite Schistosoma mansoni. FEBS J (2006) 1.14
Excretory/secretory-products of Echinococcus multilocularis larvae induce apoptosis and tolerogenic properties in dendritic cells in vitro. PLoS Negl Trop Dis (2012) 1.13
Hepatic infestation of Echinococcus multilocularis with extension to regional lymph nodes. Langenbecks Arch Surg (2009) 1.12
Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study. Malar J (2012) 1.10
Cloning and characterisation of Schistosoma japonicum insulin receptors. PLoS One (2010) 1.10
Characterisation of EmMPK1, an ERK-like MAP kinase from Echinococcus multilocularis which is activated in response to human epidermal growth factor. Int J Parasitol (2006) 1.09
Echinococcus multilocularis infection of several Old World monkey species in a breeding enclosure. Am J Trop Med Hyg (2007) 1.06
Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures. Methods Mol Biol (2009) 1.05
Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe. Malar J (2002) 1.04
Immunochromatographic test with recombinant Em18 antigen for the follow-up study of alveolar echinococcosis. Clin Vaccine Immunol (2011) 1.03
Structured treatment interruption in patients with alveolar echinococcosis. Hepatology (2004) 1.02
Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg (2008) 1.01
Serological confirmatory testing of alveolar and cystic echinococcosis in clinical practice: results of a comparative study with commercialized and in-house assays. Clin Lab (2009) 1.00
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus. Clin Infect Dis (2010) 0.99
Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography. Abdom Imaging (2007) 0.99
Immunoglobulin G subclass responses to recombinant Em18 in the follow-up of patients with alveolar echinococcosis in different clinical stages. Clin Vaccine Immunol (2010) 0.98
Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors. Biochem Pharmacol (2008) 0.97
In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae. Int J Antimicrob Agents (2012) 0.96
Identification and molecular characterisation of a gene encoding a member of the insulin receptor family in Echinococcus multilocularis. Int J Parasitol (2003) 0.96
Long-term in vitro cultivation of Echinococcus multilocularis metacestodes under axenic conditions. Parasitol Res (2004) 0.95
Echinococcus multilocularis primary cells: improved isolation, small-scale cultivation and RNA interference. Mol Biochem Parasitol (2010) 0.95
Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients. Eur J Intern Med (2003) 0.94
Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop. Malar J (2003) 0.92
Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis (2012) 0.92
Chronic granulomatous lung infection caused by the dimorphic fungus Emmonsia sp. Int J Med Microbiol (2003) 0.91
Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother (2003) 0.91
Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J Clin Immunol (2004) 0.91
Evidence for a recent horizontal transmission and spatial spread of Wolbachia from endemic Rhagoletis cerasi (Diptera: Tephritidae) to invasive Rhagoletis cingulata in Europe. Mol Ecol (2013) 0.90
Anatomy and development of the larval nervous system in Echinococcus multilocularis. Front Zool (2013) 0.89
Molecular characterisation of MEK1/2- and MKK3/6-like mitogen-activated protein kinase kinases (MAPKK) from the fox tapeworm Echinococcus multilocularis. Int J Parasitol (2009) 0.89
Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients. Clin Dev Immunol (2012) 0.89
Diagnostics in cystic echinococcosis: serology versus ultrasonography. Turk J Gastroenterol (2014) 0.88
Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis. Exp Parasitol (2008) 0.88
In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae. Antimicrob Agents Chemother (2006) 0.87
A member of the transforming growth factor-beta receptor family from Echinococcus multilocularis is activated by human bone morphogenetic protein 2. Mol Biochem Parasitol (2006) 0.86
Human cystic echinococcosis in South Africa. Acta Trop (2011) 0.85
MoMa from patients with systemic lupus erythematosus show altered adhesive activity. Autoimmunity (2009) 0.85
First insights into species and genotypes of Echinococcus in South Africa. Vet Parasitol (2013) 0.85
Survey of public knowledge about Echinococcus multilocularis in four European countries: need for proactive information. BMC Public Health (2008) 0.84
Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes. Cytometry A (2008) 0.84
A hundred years of controversy about the taxonomic status of Echinococcus species. Acta Trop (2010) 0.84
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75. J Neurol (2015) 0.83
Evaluation of a commercial Echinococcus Western Blot assay for serological follow-up of patients with alveolar echinococcosis. Clin Vaccine Immunol (2008) 0.83
Three-dimensional reconstruction of Echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Trop Med Hyg (2010) 0.83
Cystic echinococcosis in South Africa: the worst yet to come? Acta Trop (2013) 0.82
Prognostic factors for invasive aspergillosis in patients with haematological malignancies. Scand J Infect Dis (2009) 0.82
Palliative operation for the treatment of alveolar echinococcosis. Langenbecks Arch Surg (2008) 0.81
Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia. Artif Organs (2003) 0.81
Increased activation and oligoclonality of peripheral CD8(+) T cells in the chronic human helminth infection alveolar echinococcosis. Infect Immun (2002) 0.81
Special issue: Experimental studies in echinococcosis. Exp Parasitol (2008) 0.80
Cytosine methylation is a conserved epigenetic feature found throughout the phylum Platyhelminthes. BMC Genomics (2013) 0.80
Prevalence of the metabolic syndrome in southwest Germany. Scand J Clin Lab Invest Suppl (2005) 0.80
Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir. AIDS (2004) 0.80
Update on glycopeptide use in german university hospitals. Infection (2004) 0.80
Long-term benzimidazole treatment of alveolar echinococcosis with hematogenic subcutaneous and bone dissemination. Med Microbiol Immunol (2003) 0.80
Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol (2004) 0.80
Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite. Parasitol Res (2010) 0.79
Molecular characterisation of a serum-responsive, DAF-12-like nuclear hormone receptor of the fox-tapeworm Echinococcus multilocularis. J Cell Biochem (2011) 0.79
Molecular cloning and characterization of Ras- and Raf-homologues from the fox-tapeworm Echinococcus multilocularis. Mol Biochem Parasitol (2005) 0.79
Molecular characterisation of a second structurally unusual AR-Smad without an MH1 domain and a Smad4 orthologue from Echinococcus multilocularis. Int J Parasitol (2007) 0.79
Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode. Infect Immun (2009) 0.79
Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine. PLoS One (2010) 0.78
Detection of low level cryoglobulins by flow cytometry. Cytometry A (2012) 0.78
Prevalence and diversity of cystic echinococcosis in livestock in Maasailand, Kenya. Parasitol Res (2012) 0.78
Pregnancy is not a risk factor for gallstone disease: results of a randomly selected population sample. World J Gastroenterol (2005) 0.78
Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease. Med Microbiol Immunol (2014) 0.77
Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population. BMC Gastroenterol (2009) 0.77
Combined albendazole and amphotericin B against Echinococcus multilocularis in vitro. Acta Trop (2010) 0.77
Echinococcus multilocularis: molecular characterization of EmSmadE, a novel BR-Smad involved in TGF-β and BMP signaling. Exp Parasitol (2011) 0.77
Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines. BioDrugs (2003) 0.77
In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis. Parasitol Res (2013) 0.77
Echinococcus multilocularis: identification and molecular characterization of a Ral-like small GTP-binding protein. Exp Parasitol (2004) 0.77
Echinococcus multilocularis: cloning and characterization of a member of the SNW/SKIP family of transcriptional coregulators. Exp Parasitol (2005) 0.77
Breast cancer mastectomy trends between 2006 and 2010: association with magnetic resonance imaging, immediate breast reconstruction, and hospital volume. Ann Surg Oncol (2013) 0.76